Journal article

The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene

Patricia McGettigan, Lisa F Lincz, John Attia, Patrick McElduff, Linda Bissett, Roseanne Peel, Barrie Stokes, Stephen Hancock, Kim Henderson, Michael Seldon, David Henry

British Journal of Clinical Pharmacology | WILEY | Published : 2011


Funding Acknowledgements

MS, LL and LB have received funds for research from Pfizer.The study was supported by grants from the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia. Financial support for reagents used in the genotyping of samples was provided to Dr Michael Seldon's laboratory by Pfizer Australia. None of the funders had any involvement in the design analysis or reporting of the study. We are grateful to all who participated in the Hunter Community Study